| Attributes | Values |
|---|
| rdf:type
| |
| http://linked.open...gbank/description
| - A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of cytochrome P-450 metabolic activity in liver function tests. [PubChem] (en)
|
| http://linked.open...generalReferences
| - # Rating D, Langhans CD: Breath tests: concepts, applications and limitations. Eur J Pediatr. 1997 Aug;156 Suppl 1:S18-23. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/9266210 (en)
|
| http://linked.open...gy/drugbank/group
| - approved (en)
- withdrawn (en)
|
| http://linked.open...ugbank/indication
| - Formerly widely used as an antipyretic and analgesic in rheumatism, neuritis, and common colds. Currently used to measure total body water. (en)
|
| sameAs
| |
| Title
| |
| adms:identifier
| |
| http://linked.open...mechanismOfAction
| - Aminophenazone is metabolized very slowly by normal newborn babies. In older infants, a higher amount of exhaled 13-CO2 is observed. (en)
|
| http://linked.open.../drugbank/synonym
| - 4-Dimethylaminoantipyrine (en)
- Aminopyrine (en)
- Dipyrine (en)
- Aminofenazone (en)
- Dimethylaminoantipyrine (en)
- Dimethylaminophenazone (en)
- 1-Phenyl-2,3-dimethyl-4-(dimethylamino)-5-pyrazolone (en)
- (Dimethylamino)phenazone (en)
- 1,5-Dimethyl-4-dimethylamino-2-phenyl-3-pyrazolone (en)
- 1-Phenyl-2,3-dimethyl-4-dimethylaminopyrazol-5-one (en)
- 2,3-Dimethyl-4-dimethylamino-1-phenyl-5-pyrazolone (en)
- 4-(Dimethylamino)antipyrine (en)
- 4-Dimethylamino-1-phenyl-2,3-dimethylpyrazolone (en)
- 4-Dimethylamino-2,3-dimethyl-1-phenyl-5-pyrazolone (en)
- 4-Dimethylaminophenazone (en)
- Aminofenazona (en)
- Aminophenazon (en)
- Aminophenazonum (en)
- Dimethylaminoazophene (en)
- Dimethylaminophenazon (en)
- Dimethylaminophenyldimethylpyrazolone (en)
- 4-Dimethylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (en)
- 4-(Dimethylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (en)
- 4-(Dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one (en)
- 3-Keto-1,5-dimethyl-4-dimethylamino-2-phenyl-2,3-dihydropyrazole (en)
|
| http://linked.open...drugbank/toxicity
| - Can cause life-threatening agranulocytosis. (en)
|
| http://linked.open...ugbank/IUPAC-Name
| |
| http://linked.open...gy/drugbank/InChI
| |
| http://linked.open...Molecular-Formula
| |
| http://linked.open.../Molecular-Weight
| |
| http://linked.open...noisotopic-Weight
| |
| http://linked.open...y/drugbank/SMILES
| |
| http://linked.open.../Water-Solubility
| |
| http://linked.open...ogy/drugbank/logP
| |
| http://linked.open...ogy/drugbank/logS
| |
| http://linked.open...logy/drugbank/pKa
| |
| http://linked.open...l/drug/hasATCCode
| |
| http://linked.open...nd-Acceptor-Count
| |
| http://linked.open...-Bond-Donor-Count
| |
| http://linked.open...drugbank/InChIKey
| |
| http://linked.open...urface-Area--PSA-
| |
| http://linked.open...nk/Polarizability
| |
| http://linked.open...bank/Refractivity
| |
| http://linked.open...atable-Bond-Count
| |
| http://linked.open.../affectedOrganism
| - Humans and other mammals (en)
|
| http://linked.open...aco2-Permeability
| |
| http://linked.open...casRegistryNumber
| |
| http://linked.open...drugbank/category
| |
| http://linked.open...k/Bioavailability
| |
| http://linked.open...bank/Ghose-Filter
| |
| http://linked.open...nk/MDDR-Like-Rule
| |
| http://linked.open...ank/Melting-Point
| |
| http://linked.open...k/Number-of-Rings
| |
| http://linked.open...siological-Charge
| |
| http://linked.open...bank/Rule-of-Five
| |
| http://linked.open...tional-IUPAC-Name
| |
| http://linked.open...-strongest-basic-
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)